XLX
Device
NuVasive, Inc.
Total Payments
$938,459
Transactions
72
Doctors
12
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $49,145 | 8 | 5 |
| 2023 | $164,275 | 13 | 7 |
| 2022 | $316,516 | 14 | 8 |
| 2021 | $224,821 | 15 | 8 |
| 2020 | $183,703 | 22 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $905,692 | 33 | 96.5% |
| Consulting Fee | $22,675 | 31 | 2.4% |
| Unspecified | $9,983 | 4 | 1.1% |
| Travel and Lodging | $64.00 | 1 | 0.0% |
| Food and Beverage | $44.94 | 3 | 0.0% |
Payments by Type
General
$928,476
68 transactions
Research
$9,983
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NUVA.EXP0120 An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $4,147 | 0 |
| NUVA.EXPO120 An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $3,336 | 0 |
| An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $2,500 | 0 |
Top Doctors Receiving Payments for XLX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurological Surgery | Gastonia, NC | $466,443 | 11 |
| , MD | Neurological Surgery | Phoenix, AZ | $323,978 | 5 |
| , M.D | Neurological Surgery | Las Vegas, NV | $57,535 | 7 |
| , M.D | Orthopaedic Surgery | Redwood City, CA | $56,523 | 15 |
| , M.D | Neurological Surgery | Houston, TX | $11,125 | 10 |
| Unknown | — | Greensboro, NC | $9,983 | 4 |
| , MD | Orthopaedic Surgery of the Spine | Raleigh, NC | $7,063 | 1 |
| , MD | Neurological Surgery | Charlotte, NC | $3,700 | 9 |
| , M.D | Neurological Surgery | Houston, TX | $2,000 | 6 |
| , M.D | Orthopaedic Surgery of the Spine | Rochester, MN | $64.00 | 1 |
| , M.D., M.H.S | Neurological Surgery | Los Angeles, CA | $28.93 | 1 |
| , M.D | Orthopaedic Surgery | Santa Monica, CA | $9.68 | 1 |
| , MD | Neurological Surgery | Saint Louis, MO | $6.33 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $889,315
- Globus Medical, Inc. $49,145
Product Information
- Type Device
- Total Payments $938,459
- Total Doctors 12
- Transactions 72
About XLX
XLX is a device associated with $938,459 in payments to 12 healthcare providers, recorded across 72 transactions in the CMS Open Payments database. The primary manufacturer is NuVasive, Inc..
Payment data is available from 2020 to 2024. In 2024, $49,145 was paid across 8 transactions to 5 doctors.
The most common payment nature for XLX is "Royalty or License" ($905,692, 96.5% of total).
XLX is associated with 3 research studies, including "NUVA.EXP0120 An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine" ($4,147).